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Abstract. Two sets of reaction conditions for the 
regiodivergent C2- or C5- direct arylations of oxazole are 
reported.  In both cases, phosphine-free catalysts and 
inexpensive bases were employed allowing the access to the 
arylated oxazoles in moderate to high yields.  Using 
Pd(OAc)2/KOAc as catalyst and base, regioselective C5-
arylations were observed; whereas, using Pd(acac)2/Cs2CO3 
system, the arylation occurred at the C2-position of oxazole. 
The higher reactivity of C5-H bond of oxazole as compared 
to the C2-H bond in the presence of Pd(OAc)2/KOAc system 
is consistent with a concerted metalation deprotonation  
mechanism; whereas the C2-arylation likely occurs via a 
simple base deprotonation of the oxazole C2-position.  
Then, from these C2- or C5-arylated oxazoles, a second 
palladium-catalyzed direct C-H bond arylation affords 2,5-
diaryloxazoles with two different aryl groups.  We also 
applied these sequential arylations to the straightforward 
synthesis of 2-arylphenanthro[9,10-d]oxazoles via three C-
H bond functionalization steps.  The Ru-catalyzed C-H 
arylation of the aryl unit of 2-aryloxazoles is also described. 
Keywords: palladium; oxazole; direct arylation; C-H bond 
functionalization; C-C bond formation 
Introduction 
Several aryl-substituted oxazole derivatives exhibit 
important biological properties, such as Oxaprozin 
which is a non-steroidal anti-inflammatory drug used 
to relieve the inflammation associated with arthritis 
(Figure 1).  Therefore, the discovery of general and 
simple routes to (poly)arylated oxazoles has potential 
for medicinal chemistry.   
Figure 1. Structure of Oxaprozin. 
In recent years, the direct arylation of 
(hetero)aromatics via Pd-catalyzed C–H bond 
functionalizations has brought a revolution in the 
access of arylated heteroarenes.[1,2]  This 
methodology is very attractive compared to the Stille, 
Suzuki or Negishi couplings as they do not require 
the preliminary synthesis of organometallic 
derivatives.[3]  Several examples of Pd-catalyzed 
arylations via a C-H bond functionalization of 
substituted oxazoles have been reported.[4]  In 
contrast, only a few examples of Pd-catalyzed direct 
arylations of unsubstituted oxazole have been 
described.[5-7]  In 2010, Strotman, Chobanian et al. 
reported a study dealing with the regiodivergent 
arylation (C2- vs C5-arylations) of oxazoles (Scheme 
1, top).[5c]  They revealed that the C5-arylation is 
preferred in polar solvents such as DMA associated 
to 10 mol% 2-di-tert-butylphosphino-3,4,5,6-
tetramethyl-2′,4′,6′-triisopropyl-1,1′-biphenyl (L1) as 
phosphine ligand; conversely, C2-arylation 
regioselectively took place in the nonpolar solvent 
xylene associated to 10 mol% 2-
dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl 
(L2) as phosphine ligand.  In both cases, they 
employed K2CO3/PivOH as base/additive.  By 
contrast, in 2013, Bellina et al. obtained C5-arylated 
oxazoles regioselectively using Pd(OAc)2 catalyst 
and Bu4NOAc as base without adding phosphine 
ligand.[6b]  To our knowledge, regiodivergent direct 
arylations of oxazole using phosphine-free conditions 
have not yet been described (Scheme 1, bottom).   
As a better understanding of the influence of reaction 
conditions on the regioselectivity control of the 
arylation of oxazoles is still needed, we 
reinvestigated the influence of the catalyst, base and 
solvent for these couplings.  Herein, we report i) 
conditions for the palladium-catalyzed regiodivergent 
direct arylation of oxazole using phosphine-free 
catalysts; ii) on the scope of the regioselectivity of 
C2-arylation, C5-arylation and one pot C2,C5-
diarylation; iii) on the influence of the presence of 
aryl-substituents at C2- or C5-positions of oxazole on 
their reactivity for access to C2,C5-diaryloxazoles; 
iv) on the synthesis of 2-arylphenanthro[9,10-
d]oxazoles via three successive C-H bond
functionalization steps; and v) on the Ru-catalyzed C-
H arylation of the aryl unit of 2-aryloxazoles. 
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Scheme 1. Pd-catalyzed direct arylations of oxazole. 
The free energy of activation for direct arylation of 
oxazole in the presence of Pd-catalysts via Concerted 
Metalation Deprotonation (CMD)[8] pathway has 
been calculated by Gorelsky (Figure 2).  The energy 
of activation of the C-H bond flanked by two 
heteroelements is higher (25.3 kcal mol-1), than the 
energy of activation of the C-H bond at C5-position 
(23.5 kcal mol-1).  Therefore, due to the lower energy 
of activation of the C-H bond at C5-position of 
oxazole, for reactions which proceed via a Pd-
catalyzed CMD mechanism, we expected to be able 
to control the regioselectivity in favor of C5-arylation 
using acetates as base/ligand; whereas, regioselective 
C2-arylations might be obtained in the presence of a 
quite strong base, via deprotonation of the C2-
position of oxazole. 
Figure 2. Free energy of activation (ΔG‡298K, kcal mol−1) 
for direct arylation via the CMD pathway involving an 
acetate ligand with the [Pd(C6H5)(PMe3)(OAc)] catalyst.[8]  
Results and Discussion 
3-Bromoquinoline (1 equiv.) and oxazole (2 equiv.) 
were employed as the model substrates for our study 
(Table 1).  We initially examined the influence of the 
nature of the base on the regioselectivities and yields 
using phosphine-free Pd(OAc)2 catalyst and DMA as 
the solvent.  We had previously observed that KOAc 
as base/ligand associated to Pd(OAc)2 in DMA 
promotes very efficiently the coupling of several 
heteroarenes with aryl bromides.[9]  Under these 
phosphine-free conditions, DMA and also 
heteroarenes such as oxazoles and some aryl halides 
might act as ligands to stabilize catalytically active 
Pd-species.  At 110 °C, the expected C5-
heteroarylated oxazole 1a was obtained with a 
complete regioselectivity in 78% yield (Table 1, entry 
1).  In sharp contrast, the use of Cs2CO3 (2-3 equiv.) 
as the base instead of KOAc gives rise to the C2-
heteroarylated oxazole 1b in 98-100% 
regioselectivity and in 22-37% yields (Table 1, 
entries 2-4).  The higher reactivity of C5-H bond as 
compared to the C2-H bond of oxazoles in the 
presence of Pd(OAc)2/KOAc system seems to be in 
agreement with a CMD mechanism;[10] whereas the 
oxazole C2-arylation likely occurs via a simple base 
deprotonation of the oxazole C2-position.  In order to 
improve the yield in the C2-arylated oxazole 1b, the 
influence of the solvent, base and catalyst was 
examined.  The use of stronger base tBuOK, led to a 
poor conversion of 3-bromoquinoline, and the desired 
product 1b was only obtained in trace amount (Table 
1, entry 5).  The use of PdCl2, PdCl2(MeCN)2, 
PdCl2(PhCN)2 and Pd(dba)2 catalysts using Cs2CO3 
as base, afforded 1b in similar regioselectivities and 
yields than Pd(OAc)2 (Table 1, entries 6-9).  The 
reactions performed in other solvents such as DMF 
and NMP gave 1b in poor yields; whereas, the use of 
xylene was ineffective (Table 1, entries 10-12).  
Pd(acac)2 catalyst using KOAc as the base gave a 
mixture of products 1a, 1b and 1c in 59:13:28 ratio 
(Table 1, entry 14).  Conversely, the use of 5 mol% 
Pd(acac)2 catalyst associated to Cs2CO3 (3 equiv.) 
was very effective, and the target C2-heteroarylated 
oxazole 1b was obtained with complete 
regioselectivity and in 65% yield (Table 1, entry 15).  
Finally, in order to obtain the C2,C5-diheteroarylated 
oxazole 1c via a one pot reaction, we employed a 
mixture of KOAc and Cs2CO3 as a mixture of bases 
(Table 1, entry 16).  To our delight, the desired 
product 1c was obtained in 80% selectivity and in 
74% yield (1a was also observed in 19% selectivity). 
The substrate scope of the C5-arylation of oxazole 
using a set of (hetero)aryl bromides was investigated 
(Scheme 2).  In the presence of 2 mol% Pd(OAc)2, 
KOAc as the base in DMA, very regioselective C5-
arylation reactions and good yields in the 5-
aryloxazoles 2a-7a were obtained using aryl 
bromides bearing nitro, cyano, formyl, propionyl, 
benzoyl or ester para-substituents.  In all cases, very 
low amounts of C2-arylated or C2,C5-diarylated 
oxazoles were detected by GC/MS and 1H NMR 
analysis of the crude mixtures.  Lower yields in 8a-
10a were obtained for the coupling aryl bromides 
para-substituted by trifluoromethyl, chloro or fluoro 
groups, owing to the formation of significant amounts 
of 2,5-diaryl oxazoles 8c-10c in the course of these 
reactions. 
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Table 1. Influence of the reaction conditions on the Pd-catalyzed arylation of oxazole with 3-bromoquinoline 
 
Entry Catalyst (mol%) Solvent Base Conv. (%) Ratio 1a:1b:1c Yield (%) 
1 Pd(OAc)2 (2) DMA KOAc 100 100:0:0 1a 78b 
2 Pd(OAc)2(5) DMA Cs2CO3 38 0:100:0 1b 22a,b 
3 Pd(OAc)2 (5) DMA Cs2CO3 42 0:100:0 1b 33b 
4 Pd(OAc)2 (5) DMA Cs2CO3  45 2:98:0 1b 37 
5 Pd(OAc)2 (5) DMA tBuOK 9 0:100:0 - 
6 PdCl2 (5) DMA Cs2CO3 33 0:100:0 - 
7 PdCl2(MeCN)2 (5) DMA Cs2CO3 40 0:100:0 - 
8 PdCl2(PhCN)2 (5) DMA Cs2CO3 28 0:100:0 - 
9 Pd(dba)2 (5) DMA Cs2CO3 36 0:100:0 - 
10 PdCl2(MeCN)2 (5) DMF Cs2CO3 31 0:100:0 - 
11 PdCl2(MeCN)2 (5) NMP Cs2CO3 20 0:100:0 - 
12 PdCl2(MeCN)2 (5) xylene Cs2CO3 3 - - 
13 Pd/C 10% (5) DMA Cs2CO3 8 0:100:0 - 
14 Pd(acac)2 (5) DMA KOAc 100 59:13:28 - 
15 Pd(acac)2 (5) DMA Cs2CO3 100 0:100:0 1b 65 
16 Pd(acac)2 (5) DMA Cs2CO3/KOAc 100 19:1:80 1c 74c 
Conditions: 3-Bromoquinoline (1 equiv.), oxazole (2 equiv.), base (3 equiv.), 24 h, 110 °C, conversion of 3-
bromoquinoline, isolated yields. a) 100 °C. b) Base 2 equiv. c) 3-Bromoquinoline (3 equiv.), oxazole (1 equiv.), Cs2CO3 (3 
equiv.) and KOAc (3 equiv.) as mixture of bases, 48 h, conversion of oxazole. 
With the electron-rich aryl bromides, 4-tert-
butylbromobenzene and 4-bromoanisole, the 5-
aryloxazoles 12a and 13a were also obtained in 
moderate yields of 52% and 46%, respectively due to 
a partial conversion of these aryl bromides.  Cyano-, 
acetyl- and chloro-substituents at meta-position on 
the aryl bromide were also tolerated giving access to 
the corresponding 5-aryloxazoles 14a-16a in 58-81% 
yields.  Reactions with more hindered, 2-
bromonitrobenzene, 2-bromobenzonitrile, 2-
bromobenzaldehyde and 1-bromonaphthalene were 
also successful providing the products 17a-19a and 
21a in 73-90% yields.   
 
Scheme 2. Scope of the C5-arylation of oxazole. 
The N-containing heterocycles, 3- or 4-
bromopyridines, and 4-bromoisoquinoline also 
regioselectively afforded the desired C5-arylated 
oxazole derivatives 22a-24a in 81-87% yields. 
 
Then, the scope of the C2-arylation of oxazole using 
Pd(acac)2/Cs2CO3 as catalytic system was examined 
(Scheme 3).  Lower yields were generally obtained 
than for the C5-arylations.  However, in all cases, 
very regioselective C2-arylations were observed.  
From para-substituted aryl bromides bearing 
electron-withdrawing – e.g. cyano or chloro – or 
electron-donating – e.g. tert-butyl or methoxy – 
groups, similar yields in the C2-arylated oxazoles b 
were obtained.  Moreover, meta- or ortho-
substituents on the aryl bromide and also 3- or 4-
bromopyridines also afforded the desired products 
14b-23b in 58-80% yields. 
 
Scheme 3. Scope of the C2-arylation of oxazole. 
10.1002/adsc.201900641
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Advanced Synthesis & Catalysis
 4 
The synthesis of 2,5-diarylated oxazoles from 
oxazole in a single pot was then examined (Scheme 
4).  As shown in the table 1 and schemes 2 and 3, the 
site selectivity for the arylation of oxazole is highly 
dependent on the presence of acetates for C5-
arylation and on the use of a quite strong base for C2-
arylation.  Based on these results, we assumed that a 
mixture of KOAc and Cs2CO3 as a base might 
promote the one pot oxazole 2,5-diarylation.  The 
reaction of oxazole with 3 equiv. of 4-
bromobenzonitrile, 3 equiv. of KOAc and 3 equiv. of 
Cs2CO3 in the presence of 5 mol% Pd(acac)2 catalyst 
afforded the desired 2,5-diaryloxazoles 3c in only 
17% yield, revealing that with a highly electron-
deficient aryl bromide, the second arylation is much 
slower than the first one.  Conversely, under the same 
conditions, the reactions with 4-trifluoro-, 4-chloro- 
and 4-fluoro-substituted aryl bromides afforded the 
target products 8c-10c in 60-73% yields.  2,5-
Diphenyloxazole 11c was also obtained in good yield 
using bromobenzene as the aryl source.  The use of 
an excess of the electron-rich aryl bromide, 4-
bromoanisole (3 equiv.) in the presence of 5 mol% 
Pd(acac)2 catalyst gave the desired diarylated product 
12c in 53% yield.  1-Bromonaphthalene was also 
successfully employed for the one-pot synthesis of 
the 2,5-diarylated oxazole 21c.  In order to determine 
the most reactive arylation site under these conditions, 
the selectivity of the reaction with 4-
chlorobromobenzene was measured at 1 h.  A mixture 
of 9a:9b:9c with a ratio of 26:63:11 was obtained, 
indicating that under these conditions, the C2-
arylation is favored.  
 
Scheme 4. Scope of the C2,C5-diarylation of oxazole. 
We performed two competition reactions to probe the 
oxazoles C2-substituent preference of the Pd(OAc)2 
catalyst for the C5-arylation (Scheme 5).  From an 
equimolar mixture of oxazole and 2-(4-
methoxyphenyl)oxazole 13b using 4-
bromobenzonitrile as the aryl source, in the presence 
of 2 mol% Pd(OAc)2 associated to KOAc as base, the 
formation of the 2,5-diaryloxazole 25 was observed 
in 85% selectivity; whereas, 5-aryloxazole 3a was 
only produced in 15% selectivity (Scheme 5, a).  
When an equimolar mixture of oxazole and 4-
(oxazol-2-yl)benzonitrile 3b was used, the ratio 
between the diaryloxazole 3c and 5-aryloxazole 3a 
was 64:36 (Scheme 5, b).  These results indicate that 
arylated oxazoles react faster than oxazole and that 
the presence of an electron-rich aryl at the C2-
position of oxazole favors the C5-arylation. 
 
 
Scheme 5. Competition reactions for the C5-arylation of 
oxazoles. 
Then, we performed two competition reactions from 
an equimolar mixture of oxazole and the 5-
aryloxazoles 3a and 13a using again 4-
bromobenzonitrile as the aryl source, in the presence 
of 5 mol% Pd(acac)2 associated to Cs2CO3 as base 
(Scheme 6).  The formation of the 2,5-diaryloxazoles 
26 and 3c was observed in 52% selectivity from 
oxazole and 13a, and 89% selectivity from oxazole 
and 3a.  The presence of an electron-deficient aryl 
group at the oxazole C5-position stongly favors the 
C2-arylation. 
 
Scheme 6. Competition reactions for C2-arylation of 
oxazoles. 
10.1002/adsc.201900641
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Advanced Synthesis & Catalysis
 5 
Based on these results, we prepared a set of non-
symmetrical 2,5-diaryl oxazoles (Scheme 7).  From 
the C2-arylated oxazoles 3b and 13b and a set of 
electron-rich or -poor aryl bromides, the 2,5-diaryl 
oxazoles 25-28 were obtained in high yields.  We 
observed in the scheme 6b that an oxazole substituted 
by an electron-deficient arene at C5-position favors 
the C2-arylation.  Indeed, from 3a and 4-
bromofluorobenzene or 4-tert-butylbromobenzene, 
the products 29 and 30 were obtained in good yields.  
The synthesis of 3c via successive C5- followed by 
C2-arylation also afforded the expected product in a 
good 66% yield.  In contrast, the reaction of 13a with 
4-bromobenzonitrile gave the 2,5-diaryl oxazole 26 in 
only 16% yield.  Therefore, the preparation of 26 via 
a C2- followed by C5-arylation sequence should be 
preferred. 
 
 
Scheme 7. Synthesis of C2,C5-diaryloxazoles via 
successive arylations. 
We also applied the regiocontrolled sequential 
arylation of oxazole to the synthesis of 2-
arylphenanthro[9,10-d]oxazoles (Scheme 8).  From 
the previously prepared 2-aryloxazoles 8b, 9b and 
13b, the introduction of a biphenyl unit at C5-
position proceed in 80-88% yields using 2-
bromobiphenyl in the presence of 2 mol% Pd(OAc)2 
catalyst.  Then, the bromination of the 4-position of 
the oxazole unit of 31a-33a with N-
bromosuccinimide gave the 4-bromooxazoles 31b-
33b in 83-86% yield.  Finally, the Pd-catalyzed 
intramolecular C-H bond arylations of 31b-33b using 
2 mol% of PdCl(C3H5)(dppb) [dppb: 1,4-
bis(diphenylphosphino)butane] catalyst with 2 equiv. 
of PivOK as the base in DMA at 150 °C – as it was 
previously demonstrated that these conditions are 
very effective to promote the C-H bond cleavage of 
benzene derivatives[11] – afforded the target -
extended polycyclic heteroaromatic hydrocarbons 
31c-33c in almost quantitative yields.  In the course 
of these synthesis, the three C-H bonds of oxazole 
were successively arylated. 
 
 
 
Scheme 8. Synthesis of 2-arylphenanthro[9,10-d]oxazoles 
via successive arylations. 
To our knowledge, only two examples of Ru-
catalyzed C-H arylations of the aryl unit of 2-
aryloxazoles have been reported so far.[12]  To 
demonstrate that, using an appropriate catalytic 
system, not only the oxazole C-H bonds are reactive, 
we also studied the reactivity of the aryl substituent 
of the 2-aryloxazoles 18b and 21b in Ru-catalyzed 
direct arylations (Scheme 9).  For these reactions, 
[Ru(p-cymene)Cl2]2 was employed as the catalyst and 
KOPiv as the base.  With the electron-rich and -poor 
aryl bromides 4-bromoanisole and 4-
bromobenzonitrile, regioselective arylations of the 
aryl unit of 18b were observed affording the products 
34 and 35 in moderate yields.  A higher yield of 83% 
in 36 was obtained for the arylation of 2-(naphthalen-
1-yl)oxazole 21b. 
 
 
Scheme 9. Ru-catalyzed direct arylation of C2-arylated 
oxazoles. 
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Conclusion 
In summary, we demonstrated that the 
regioselectivity of the direct arylation of oxazole can 
be controlled using the appropriate phosphine-free 
palladium catalyst/base system.  From Pd(OAc)2 
catalyst associated to KOAc, regioselective C5-
arylations were observed; whereas, the use of 
Pd(acac)2 catalyst associated to Cs2CO3 led to the C2-
arylated oxazoles.  A wide variety of (hetero)aryl 
bromides were tolerated by these reaction conditions.  
The access to 2,5-diaryloxazoles bearing identical or 
different aryl groups via one-pot diarylation or 
sequential arylations is also described.  These 
sequential arylation allowed the straightforward 
synthesis of 2-arylphenanthro[9,10-d]oxazoles in 
good yields via three C-H bond functionalization 
steps.  Using Ru-catalysis, the C-H arylation of the 
aryl unit of 2-aryloxazoles is also possible.  These 
phosphine-free regiodivergent procedures employ 
easily available catalysts, bases and substrates and 
tolerate a variety of useful functional groups.  For 
these reasons, these protocols provide economically 
viable and environmentally very attractive accesses to 
(poly)arylated oxazole derivatives.   
Experimental Section 
General procedures for palladium-catalyzed direct 
(di)arylations of oxazoles: 
Procedure A: The reaction of the aryl bromide (1 or 2 
mmol) (see schemes), oxazole derivative (1 or 2 mmol) 
(see schemes), KOAc (0.196 g, 2 mmol) in the presence of 
Pd(OAc)2 (2.4 mg, 0.02 mmol) at 100 or 110 °C (see 
schemes) during 24 h in DMA (4 mL) under argon affords 
the coupling products 1a-24a, 25-28 and 31a-33a after 
evaporation of the solvent and purification on silica gel.  
Eluent heptane:ethyl acetate: 3:7 for 23a; 4:6 for 22a; 6:4 
for 1a, 14a, 24a; 7:3 for 2a-4a, 6a, 7a, 13a, 15a, 17a-19a, 
25-27; 8:2 for 5a, 8a, 10a-12a, 16a, 20a, 21a, 28, 31a; 9:1 
for 9a, 32a, 33a. 
Procedure B: The reaction of the aryl bromide (1 or 2 
mmol) (see schemes), oxazole derivative (1 or 2 mmol) 
(see schemes), Cs2CO3 (0.975 g, 3 mmol) in the presence 
of Pd(acac)2 (15.2 mg, 0.05 mmol) at 110 °C during 24 h 
in DMA (4 mL) under argon affords the coupling products 
1b-23b, 29 and 30 after evaporation of the solvent and 
purification on silica gel.  Eluent heptane:ethyl acetate: 6:4 
for 1b, 22b; 7:3 for 14b, 18b, 29, 30; 8:2 for 3b-13b, 16b, 
23b; 9:1 for 21b. 
Procedure C: The reaction of the aryl bromide (3 mmol), 
oxazole (0.069 g, 1 mmol), KOAc (0.294 g, 3 mmol) 
Cs2CO3 (0.975 g, 3 mmol) in the presence of Pd(acac)2 
(15.2 mg, 0.05 mmol) at 110 °C during 48 h in DMA (4 
mL) under argon affords the coupling products 1c-21c 
after evaporation of the solvent and purification on silica 
gel.  Eluent heptane:ethyl acetate: 3:7 for 1c, 7:3 for 3c, 
13c; 8:2 for 8c, 10c, 11c; 9:1 for 9c, 21c. 
5-(Quinolin-3-yl)oxazole (1a):[17] Following procedure A, 
from 3-bromoquinoline (0.208 g, 1 mmol) and oxazole 
(0.138 g, 2 mmol), product 1a was obtained in 78% yield 
(0.153 g) as a brown solid: mp 136-138 °C.  1H NMR (400 
MHz, CDCl3):  9.18 (d, J = 2.0 Hz, 1H), 8.37 (d, J = 2.0 
Hz, 1H), 8.11 (d, J = 8.1 Hz, 1H), 8.02 (s, 1H), 7.86 (d, J = 
8.1 Hz, 1H), 7.73 (t, J = 7.9 Hz, 1H), 7.58 (t, J = 7.9 Hz, 
1H), 7.56 (s, 1H).  13C NMR (100 MHz, CDCl3):  151.2, 
149.2, 147.7, 146.7, 130.6, 130.1, 129.5, 128.1, 127.6, 
127.5, 122.9, 121.1.  LRMS calcd for M+ C12H8N2O 196, 
found 196. 
5-(4-Nitrophenyl)oxazole (2a):[6b] Following procedure 
A, from 4-bromonitrobenzene (0.202 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 2a was obtained in 
80% yield (0.152 g) as a yellow solid: mp 149-151 °C.  1H 
NMR (400 MHz, CDCl3):  8.28 (d, J = 8.9 Hz, 2H), 8.01 
(s, 1H), 7.81 (d, J = 8.9 Hz, 2H), 7.56 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  151.8, 149.5, 147.4, 133.4, 124.8, 
124.7, 124.5.  LRMS calcd for M+ C9H6N2O3 190, found 
190. 
4-(Oxazol-5-yl)benzonitrile (3a):[13] Following procedure 
A, from 4-bromobenzonitrile (0.182 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 3a was obtained in 
80% yield (0.133 g) as a white solid: mp 151-153 °C.  1H 
NMR (400 MHz, CDCl3):  7.98 (s, 1H), 7.76 (d, J = 8.6 
Hz, 2H), 7.71 (d, J = 8.6 Hz, 2H), 7.50 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  151.5, 149.8, 132.8, 131.7, 124.7, 
124.2, 118.4, 112.0.  LRMS calcd for M+ C10H6N2O 170, 
found 170. 
4-(Oxazol-5-yl)benzaldehyde (4a):[14] Following 
procedure A, from 4-bromobenzaldehyde (0.185 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 4a was 
obtained in 73% yield (0.126 g) as a white solid: mp 101-
103 °C.  1H NMR (400 MHz, CDCl3):  10.02 (s, 1H), 
7.99 (s, 1H), 7.94 (d, J = 8.5 Hz, 2H), 7.80 (d, J = 8.5 Hz, 
2H), 7.52 (s, 1H).  13C NMR (100 MHz, CDCl3):  191.4, 
151.6, 150.5, 136.1, 133.1, 130.6, 124.8, 124.2.  LRMS 
calcd for M+ C10H7NO2 173, found 173. 
1-(4-(Oxazol-5-yl)phenyl)propan-1-one (5a): Following 
procedure A, from 4-bromopropiophenone (0.213 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 5a was 
obtained in 73% yield (0.159 g) as a white solid: mp 87-
89 °C.  1H NMR (400 MHz, CDCl3):  8.03 (d, J = 8.5 Hz, 
2H), 7.97 (s, 1H), 7.75 (d, J = 8.5 Hz, 2H), 7.49 (s, 1H), 
3.01 (q, J = 7.6 Hz, 2H), 1.24 (t, J = 7.6 Hz, 3H).  13C 
NMR (100 MHz, CDCl3):  199.9, 151.2, 150.5, 136.5, 
131.6, 128.7, 124.3, 123.4, 31.8, 8.3.  Anal. Calcd for 
C12H11NO2 (201.23): C, 71.63; H, 5.51. Found: C, 71.78; 
H, 5.39.  LRMS calcd for M+ C12H11NO2 201, found 201. 
(4-(Oxazol-5-yl)phenyl)(phenyl)methanone (6a): 
Following procedure A, from 4-bromobenzophenone 
(0.261 g, 1 mmol) and oxazole (0.138 g, 2 mmol), KOAc 
(0.196 g, 2 mmol), product 6a was obtained in 76% yield 
(0.189 g) as a yellow solid: mp 129-131 °C.  1H NMR (400 
MHz, CDCl3):  7.97 (s, 1H), 7.86 (d, J = 8.5 Hz, 2H), 
7.79 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 7.59 (t, J 
= 7.9 Hz, 1H), 7.51-7.46 (m, 3H).  13C NMR (100 MHz, 
CDCl3):  195.7, 151.2, 150.6, 137.4, 137.3, 132.6, 131.2, 
130.8, 129.9, 128.4, 124.0, 123.4.  Anal. Calcd for 
C16H11NO2 (249.27): C, 77.10; H, 4.45. Found: C, 77.02; 
H, 4.66.  HRMS calcd for M+Na C16H11NNaO2 272.0682, 
found 272.0683. 
Ethyl 4-(oxazol-5-yl)benzoate (7a): Following procedure 
A, from ethyl 4-bromobenzoate (0.229 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 7a was obtained in 
74% yield (0.160 g) as a yellow solid: mp 73-75 °C.  1H 
NMR (400 MHz, CDCl3):  8.09 (d, J = 8.5 Hz, 2H), 7.95 
(s, 1H), 7.71 (d, J = 8.5 Hz, 2H), 7.46 (s, 1H), 4.40 (q, J = 
7.6 Hz, 2H), 1.40 (t, J = 7.6 Hz, 3H).  13C NMR (100 MHz, 
CDCl3):  165.9, 151.1, 150.6, 131.6, 130.3, 130.2, 124.1, 
123.3, 61.2, 14.3.  Anal. Calcd for C12H11NO3 (217.22): C, 
66.35; H, 5.10. Found: C, 66.54; H, 4.89.  HRMS calcd for 
M+Na C12H11NNaO3 240.0631, found 240.0632.  
5-(4-(Trifluoromethyl)phenyl)oxazole (8a):[15a] 
Following procedure A, from 4-
(trifluoromethyl)bromobenzene (0.225 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 8a was obtained in 
56% yield (0.119 g) as a yellow solid: mp 70-72 °C.  1H 
NMR (400 MHz, CDCl3):  7.97 (s, 1H), 7.77 (d, J = 8.5 
Hz, 2H), 7.69 (d, J = 8.5 Hz, 2H), 7.47 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  151.4, 150.4, 131.1, 130.6 (q, J = 
32.5 Hz), 126.1 (q, J = 3.7 Hz), 124.7, 124.0 (q, J = 272.1 
Hz), 122.9.  LRMS calcd for M+ C10H6F3NO 213, found 
213. 
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5-(4-Chlorophenyl)oxazole (9a):[15b] Following procedure 
A, from 4-bromochlorobenzene (0.191 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 9a was obtained in 
55% yield (0.098 g) as a white solid: mp 69-71 °C.  1H 
NMR (400 MHz, CDCl3):  7.91 (s, 1H), 7.58 (d, J = 8.4 
Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.35 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  150.8, 134.7, 129.4, 126.4, 125.8, 
122.0.  LRMS calcd for M+ C9H6ClNO 179, found 179. 
5-(4-Fluorophenyl)oxazole (10a):[16] Following procedure 
A, from 4-bromofluorobenzene (0.175 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 10a was obtained in 
66% yield (0.107 g) as a white solid: mp 43-45 °C.  1H 
NMR (400 MHz, CDCl3):  7.90 (s, 1H), 7.63 (dd, J = 8.6, 
5.2 Hz, 2H), 7.29 (s, 1H), 7.12 (t, J = 8.6 Hz, 2H).  13C 
NMR (100 MHz, CDCl3):  162.9 (d, J = 249.0 Hz), 150.9, 
150.6, 126.4 (d, J = 8.3 Hz), 124.2 (d, J = 4.5 Hz), 121.3, 
116.2 (d, J = 22.1 Hz).  LRMS calcd for M+ C9H6FNO 
163, found 163. 
5-Phenyloxazole (11a):[15b] Following procedure A, from 
bromobenzene (0.157 g, 1 mmol) and oxazole (0.138 g, 2 
mmol), product 11a was obtained in 74% yield (0.107 g) 
as a yellow solid: mp 45-47 °C.  1H NMR (400 MHz, 
CDCl3):  7.92 (s, 1H), 7.66 (d, J = 8.4 Hz, 2H), 7.43 (t, J 
= 8.0 Hz, 2H), 7.38-7.31 (m, 2H).  13C NMR (100 MHz, 
CDCl3):  151.7, 150.6, 129.1, 128.8, 127.9, 124.5, 121.6.  
LRMS calcd for M+ C9H7NO 145, found 145. 
5-(4-(tert-Butyl)phenyl)oxazole (12a):[17] Following 
procedure A, from 1-bromo-4-tert-butylbenzene (0.213 g, 
1 mmol) and oxazole (0.138 g, 2 mmol), product 12a was 
obtained in 52% yield (0.104 g) as a yellow solid: mp 43-
45 °C.  1H NMR (400 MHz, CDCl3):  7.89 (s, 1H), 7.59 
(d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 7.31 (s, 1H), 
1.34 (s, 9H).  13C NMR (100 MHz, CDCl3):  151.9, 151.7, 
150.2, 125.9, 125.0, 124.2, 121.0, 34.8, 31.2.  LRMS calcd 
for M+ C13H15NO 201, found 201. 
5-(4-Methoxyphenyl)oxazole (13a):[6b] Following 
procedure A, from 4-bromoanisole (0.187 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 13a was obtained in 
46% yield (0.080 g) as an orange solid: mp 63-65 °C.  1H 
NMR (400 MHz, CDCl3):  7.86 (s, 1H), 7.58 (d, J = 8.4 
Hz, 2H), 7.22 (s, 1H), 6.95 (d, J = 8.4 Hz, 2H), 3.83 (s, 
3H).  13C NMR (100 MHz, CDCl3):  160.1, 151.7, 150.0, 
126.1, 120.7, 120.1, 114.5, 55.5.  LRMS calcd for M+ 
C10H9NO2 175, found 175. 
3-(Oxazol-5-yl)benzonitrile (14a):[14] Following 
procedure A, from 3-bromobenzonitrile (0.182 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 14a was obtained 
in 81% yield (0.138 g) as a white solid: mp 148-150 °C.  
1H NMR (400 MHz, CDCl3):  7.97 (s, 1H), 7.93 (s, 1H), 
7.86 (dt, J = 7.9, 1.5 Hz, 1H), 7.61 (dt, J = 7.8, 1.3 Hz, 
1H), 7.55 (t, J = 7.8 Hz, 1H), 7.45 (s, 1H).  13C NMR (100 
MHz, CDCl3):  151.4, 149.5, 131.9, 130.0, 129.1, 128.4, 
127.9, 123.3, 118.2, 113.6.  LRMS calcd for M+ C10H6N2O 
170, found 170. 
1-(3-(Oxazol-5-yl)phenyl)ethan-1-one (15a): Following 
procedure A, from 3-bromoacetophenone (0.199 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 15a was 
obtained in 75% yield (0.140 g) as a white solid: mp 61-
63 °C.  1H NMR (400 MHz, CDCl3):  8.22 (s, 1H), 7.95 
(s, 1H), 7.90 (dt, J = 7.9, 1.5 Hz, 1H), 7.82 (dt, J = 7.8, 1.3 
Hz, 1H), 7.53 (t, J = 7.8 Hz, 1H), 7.44 (s, 1H), 2.64 (s, 
3H).  13C NMR (100 MHz, CDCl3):  197.4, 150.9, 150.7, 
137.7, 129.3, 128.6, 128.4, 128.3, 124.0, 122.4, 26.7.  
Anal. Calcd for C11H9NO2 (187.20): C, 70.58; H, 4.85. 
Found: C, 70.69; H, 5.02.  LRMS calcd for M+ C11H9NO2 
187, found 187. 
5-(3-Chlorophenyl)oxazole (16a):[18] Following 
procedure A, from 3-bromochlorobenzene (0.191 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 16a was 
obtained in 58% yield (0.104 g) as a white solid: mp 60-
62 °C.  1H NMR (400 MHz, CDCl3):  7.92 (s, 1H), 7.64 
(t, J = 1.4 Hz, 1H), 7.52 (dt, J = 7.6, 1.3 Hz, 1H), 7.38 (s, 
1H), 7.33 (t, J = 7.7 Hz, 1H), 7.30 (dt, J = 7.0, 1.3 Hz, 1H).  
13C NMR (100 MHz, CDCl3):  150.8, 150.3, 135.0, 130.2, 
129.4, 128.6, 124.4, 122.5, 122.4.  LRMS calcd for M+ 
C9H6ClNO 179, found 179. 
5-(2-Nitrophenyl)oxazole (17a):[19] Following procedure 
A, from 2-bromonitrobenzene (0.202 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 17a was obtained in 
88% yield (0.167 g) as a yellow solid: mp 82-84 °C.  1H 
NMR (400 MHz, CDCl3):  7.97 (s, 1H), 7.86 (dd, J = 8.1, 
1.0 Hz, 1H), 7.72 (dd, J = 7.8, 1.5 Hz, 1H), 7.67 (td, J = 
7.8, 1.0 Hz, 1H), 7.54 (td, J = 7.8, 1.5 Hz, 1H), 7.40 (s, 
1H).  13C NMR (100 MHz, CDCl3):  151.8, 147.7, 146.6, 
132.7, 129.9, 129.8, 126.0, 124.6, 121.7.  LRMS calcd for 
M+ C9H6N2O3 190, found 190. 
2-(Oxazol-5-yl)benzonitrile (18a):[14] Following 
procedure A, from 2-bromobenzonitrile (0.182 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 18a was obtained 
in 90% yield (0.153 g) as a white solid: mp 113-115 °C.  
1H NMR (400 MHz, CDCl3):  8.01 (s, 1H), 7.94 (s, 1H), 
7.85 (d, J = 8.0 Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.68 (t, J 
= 7.8 Hz, 1H), 7.43 (t, J = 7.8 Hz, 1H).  13C NMR (100 
MHz, CDCl3):  151.3, 147.8, 134.2, 133.3, 130.5, 128.6, 
126.5, 126.2, 118.3, 108.0.  LRMS calcd for M+ C10H6N2O 
170, found 170. 
2-(Oxazol-5-yl)benzaldehyde (19a):[14] Following 
procedure A, from 2-bromobenzaldehyde (0.185 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 19a was 
obtained in 75% yield (0.130 g) as a yellow solid: mp 99-
101 °C.  1H NMR (400 MHz, CDCl3):  10.31 (s, 1H), 
8.05 (s, 1H), 8.01 (d, J = 7.8 Hz, 1H), 7.70-7.63 (m, 2H), 
7.53 (t, J = 7.8 Hz, 1H), 7.38 (s, 1H).  13C NMR (100 
MHz, CDCl3):  191.1, 151.9, 148.7, 134.0, 133.5, 129.7, 
129.5, 129.1, 129.0, 126.6.  LRMS calcd for M+ C10H7NO2 
173, found 173. 
5-(Naphthalen-2-yl)oxazole (20a):[20] Following 
procedure A, from 2-bromonaphthalene (0.207 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 20a was obtained 
in 55% yield (0.107 g) as an orange solid: mp 116-118 °C.  
1H NMR (400 MHz, CDCl3):  8.13 (s, 1H), 7.97 (s, 1H), 
7.90-7.81 (m, 3H), 7.72 (dd, J = 8.5, 1.4 Hz, 1H), 7.55-
7.49 (m, 2H), 7.47 (s, 1H).  13C NMR (100 MHz, CDCl3): 
 151.7, 150.6, 133.3, 133.2, 128.8, 128.3, 127.8, 126.8, 
126.6, 125.0, 123.3, 122.1, 122.0.  LRMS calcd for M+ 
C13H9NO 195, found 195. 
5-(Naphthalen-1-yl)oxazole (21a):[13] Following 
procedure A, from 1-bromonaphthalene (0.207 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 21a was obtained 
in 73% yield (0.142 g) as a yellow solid: mp 70-72 °C.  1H 
NMR (400 MHz, CDCl3):  8.25 (d, J = 8.5 Hz, 1H), 8.07 
(s, 1H), 7.93-7.89 (m, 2H), 7.75 (dd, J = 7.7, 1.0 Hz, 1H), 
7.61-7.52 (m, 3H), 7.46 (s, 1H).  13C NMR (100 MHz, 
CDCl3):  151.0, 150.9, 134.0, 130.4, 129.9, 128.9, 127.2, 
126.8, 126.4, 125.4, 125.3, 125.0, 124.9.  LRMS calcd for 
M+ C13H9NO 195, found 195. 
5-(Pyridin-3-yl)oxazole (22a):[14] Following procedure A, 
from 3-bromopyridine (0.158 g, 1 mmol) and oxazole 
(0.138 g, 2 mmol), product 22a was obtained in 81% yield 
(0.118 g) as a colorless oil.  1H NMR (400 MHz, CDCl3):  
8.94 (s, 1H), 8.59 (d, J = 4.1 Hz, 1H), 7.98 (s, 1H), 7.93 
(dt, J = 8.0, 1.9 Hz, 1H), 7.46 (s, 1H), 7.38 (dd, J = 8.0, 4.1 
Hz, 1H).  13C NMR (100 MHz, CDCl3):  151.3, 149.7, 
148.9, 145.9, 131.6, 124.1, 123.8, 122.9.  LRMS calcd for 
M+ C8H6N2O 146, found 146. 
5-(Pyridin-4-yl)oxazole (23a):[14] Following procedure A, 
from 4-bromopyridine hydrochloride (0.194 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 23a was obtained 
in 87% yield (0.127 g) as a brown solid: mp 135-137 °C.  
1H NMR (400 MHz, CDCl3):  8.69 (bs, 2H), 8.00 (s, 1H), 
7.57 (s, 1H), 7.53 (d, J = 6.0 Hz, 2H).  13C NMR (100 
MHz, CDCl3):  151.7, 150.6, 149.2, 134.6, 124.8, 118.3.  
LRMS calcd for M+ C8H6N2O 146, found 146. 
5-(Isoquinolin-4-yl)oxazole (24a): Following procedure 
A, from 4-bromoisoquinoline (0.208 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 24a was obtained in 
84% yield (0.164 g) as a white solid: mp 117-119 °C.  1H 
NMR (400 MHz, CDCl3):  9.26 (s, 1H), 8.78 (s, 1H), 8.24 
(d, J = 8.2 Hz, 1H), 8.12 (s, 1H), 7.05 (d, J = 8.2 Hz, 1H), 
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7.80 (t, J = 7.9 Hz, 1H), 7.70 (t, J = 7.9 Hz, 1H), 7.53 (s, 
1H).  13C NMR (100 MHz, CDCl3):  153.6, 151.5, 148.4, 
142.5, 132.4, 131.5, 128.4, 128.3, 127.7, 125.7, 123.9, 
119.2.  Anal. Calcd for C12H8N2O (196.21): C, 73.46; H, 
4.11. Found: C, 73.28; H, 4.01.  HRMS calcd for M+H 
C12H9N2O 197.0709, found 197.0712. 
2-(Quinolin-3-yl)oxazole (1b): Following procedure B, 
from 3-bromoquinoline (0.208 g, 1 mmol) and oxazole 
(0.138 g, 2 mmol), product 1b was obtained in 65% yield 
(0.127 g) as a yellow solid: mp 152-154 °C.  1H NMR (400 
MHz, CDCl3):  9.55 (d, J = 2.0 Hz, 1H), 8.73 (d, J = 2.0 
Hz, 1H), 8.12 (d, J = 8.1 Hz, 1H), 7.88 (d, J = 8.1 Hz, 1H), 
7.77 (s, 1H), 7.74 (t, J = 7.9 Hz, 1H), 7.57 (t, J = 7.9 Hz, 
1H), 7.31 (s, 1H).  13C NMR (100 MHz, CDCl3):  159.9, 
148.5, 148.0, 139.3, 133.5, 130.7, 129.5, 128.8, 128.5, 
127.5, 127.2, 120.7.  Anal. Calcd for C12H8N2O (196.21): 
C, 73.46; H, 4.11. Found: C, 73.51; H, 4.05.  HRMS calcd 
for M+Na C12H8N2NaO 219.0529, found 219.0531. 
4-(Oxazol-2-yl)benzonitrile (3b):[21] Following procedure 
B, from 4-bromobenzonitrile (0.182 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 3b was obtained in 
64% yield (0.109 g) as a white solid: mp 105-107 °C.  1H 
NMR (400 MHz, CDCl3):  8.15 (d, J = 8.6 Hz, 2H), 7.78 
(d, J = 0.5 Hz, 1H), 7.76 (d, J = 8.6 Hz, 2H), 7.31 (d, J = 
0.5 Hz, 1H).  13C NMR (100 MHz, CDCl3):  160.3, 139.9, 
132.8, 131.3, 129.3, 126.9, 118.4, 113.8.  LRMS calcd for 
M+ C10H6N2O 170, found 170. 
2-(4-(Trifluoromethyl)phenyl)oxazole (8b):[21] Following 
procedure B, from 4-(trifluoromethyl)bromobenzene 
(0.225 g, 1 mmol) and oxazole (0.138 g, 2 mmol), product 
8b was obtained in 47% yield (0.100 g) as a white solid: 
mp 73-75 °C.  1H NMR (400 MHz, CDCl3):  8.17 (d, J = 
8.5 Hz, 2H), 7.77 (s, 1H), 7.73 (d, J = 8.5 Hz, 2H), 7.29 (s, 
1H).  13C NMR (100 MHz, CDCl3):  160.6, 139.4, 132.0 
(q, J = 32.6 Hz), 130.6, 128.9, 126.6, 125.8 (q, J = 3.8 Hz), 
123.9 (q, J = 272.2 Hz).  LRMS calcd for M+ C10H6F3NO 
213, found 213. 
2-(4-Chlorophenyl)oxazole (9b):[21] Following procedure 
B, from 4-bromochlorobenzene (0.191 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 9b was obtained in 
58% yield (0.104 g) as a white solid: mp 87-89 °C.  1H 
NMR (400 MHz, CDCl3):  7.98 (d, J = 8.4 Hz, 2H), 7.71 
(s, 1H), 7.44 (d, J = 8.4 Hz, 2H), 7.24 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  161.1, 138.8, 136.5, 129.1, 128.6, 
127.6, 126.0.  LRMS calcd for M+ C9H6ClNO 179, found 
179. 
2-Phenyloxazole (11b):[5c] Following procedure B, from 
bromobenzene (0.157 g, 1 mmol) and oxazole (0.138 g, 2 
mmol), product 11b was obtained in 62% yield (0.090 g) 
as a yellow oil.  1H NMR (400 MHz, CDCl3):  8.08-8.03 
(m, 2H), 7.71 (s, 1H), 7.49-7.44 (m, 3H), 7.24 (s, 1H).  13C 
NMR (100 MHz, CDCl3):  162.0, 138.6, 130.3, 128.8, 
128.4, 127.5, 126.4.  LRMS calcd for M+ C9H7NO 145, 
found 145. 
2-(4-(tert-Butyl)phenyl)oxazole (12b):[22] Following 
procedure B, from 1-bromo-4-tert-butylbenzene (0.213 g, 
1 mmol) and oxazole (0.138 g, 2 mmol), product 12b was 
obtained in 53% yield (0.106 g) as a colorless oil.  1H 
NMR (400 MHz, CDCl3):  7.98 (d, J = 8.4 Hz, 2H), 7.69 
(s, 1H), 7.48 (d, J = 8.4 Hz, 2H), 7.22 (s, 1H), 1.35 (s, 9H).  
13C NMR (100 MHz, CDCl3):  162.3, 153.9, 138.4, 128.4, 
126.3, 125.9, 124.9, 35.1, 31.3.  LRMS calcd for M+ 
C13H15NO 201, found 201. 
2-(4-Methoxyphenyl)oxazole (13b):[21] Following 
procedure B, from 4-bromoanisole (0.187 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 13b was obtained in 
64% yield (0.112 g) as a yellow oil.  1H NMR (400 MHz, 
CDCl3):  7.98 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 0.5 Hz, 
1H), 7.18 (d, J = 0.5 Hz, 1H), 6.96 (d, J = 8.4 Hz, 2H), 
3.85 (s, 3H).  13C NMR (100 MHz, CDCl3):  162.2, 161.4, 
138.1, 128.3, 128.1, 120.5, 114.3, 55.5.  LRMS calcd for 
M+ C10H9NO2 175, found 175. 
3-(Oxazol-2-yl)benzonitrile (14b):[21] Following 
procedure B, from 3-bromobenzonitrile (0.182 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 14b was obtained 
in 70% yield (0.119 g) as a white solid: mp 87-89 °C.  1H 
NMR (400 MHz, CDCl3):  8.33 (t, J = 1.5 Hz, 1H), 8.28 
(dt, J = 8.4, 1.5 Hz, 1H), 7.77 (s, 1H), 7.72 (dt, J = 8.4, 1.5 
Hz, 1H), 7.59 (t, J = 8.4 Hz, 1H), 7.29 (s, 1H).  13C NMR 
(100 MHz, CDCl3):  159.8, 139.5, 133.4, 130.3, 129.8, 
129.7, 128.9, 128.7, 118.0, 113.3.  LRMS calcd for M+ 
C10H6N2O 170, found 170. 
2-(3-Chlorophenyl)oxazole (16b):[23] Following 
procedure B, from 3-bromochlorobenzene (0.191 g, 1 
mmol) and oxazole (0.138 g, 2 mmol), product 16b was 
obtained in 61% yield (0.109 g) as a white solid: mp 43-
45 °C.  1H NMR (400 MHz, CDCl3):  8.05 (s, 1H), 7.94 
(dt, J = 8.4, 1.7 Hz, 1H), 7.73 (s, 1H), 7.44-7.37 (m, 2H), 
7.25 (s, 1H).  13C NMR (100 MHz, CDCl3):  160.7, 139.0, 
134.9, 130.3, 130.1, 129.1, 128.7, 126.5, 124.4.  LRMS 
calcd for M+ C9H6ClNO 179, found 179. 
2-(Oxazol-2-yl)benzonitrile (18b): Following procedure 
B, from 2-bromobenzonitrile (0.182 g, 1 mmol) and 
oxazole (0.138 g, 2 mmol), product 18b was obtained in 
58% yield (0.099 g) as a white solid: mp 51-53 °C.  1H 
NMR (400 MHz, CDCl3):  8.20 (dd, J = 8.0, 0.8 Hz, 1H), 
7.83 (s, 1H), 7.81 (dd, J = 7.8, 0.9 Hz, 1H), 7.70 (td, J = 
7.8, 1.2 Hz, 1H), 7.54 (td, J = 7.8, 1.2 Hz, 1H), 7.37 (s, 
1H).  13C NMR (100 MHz, CDCl3):  158.7, 139.7, 134.8, 
132.8, 130.2, 129.3, 129.1, 128.6, 117.9, 109.8.  Anal. 
Calcd for C10H6N2O (170.17): C, 70.58; H, 3.55. Found: C, 
70.66; H, 3.75.  HRMS calcd for M+Na C10H6N2NaO 
193.0372, found 193.0372. 
2-(Naphthalen-1-yl)oxazole (21b):[24] Following 
procedure B, from 1-bromonaphthalene (0.207 g, 1 mmol) 
and oxazole (0.138 g, 2 mmol), product 21b was obtained 
in 77% yield (0.150 g) as a colorless oil.  1H NMR (400 
MHz, CDCl3):  9.28 (d, J = 8.5 Hz, 1H), 8.21 (dd, J = 7.4, 
0.9 Hz, 1H), 7.96 (d, J = 8.3 Hz, 1H), 7.91 (d, J = 8.1 Hz, 
1H), 7.81 (s, 1H), 7.64 (td, J = 7.8, 1.2 Hz, 1H), 7.59-7.52 
(m, 2H), 7.39 (s, 1H).  13C NMR (100 MHz, CDCl3):  
161.8, 138.3, 133.9, 131.2, 130.2, 128.5, 128.4, 127.8, 
127.5, 126.3, 126.2, 125.0, 124.1.  LRMS calcd for M+ 
C13H9NO 195, found 195. 
2-(Pyridin-3-yl)oxazole (22b):[4a] Following procedure B, 
from 3-bromopyridine (0.158 g, 1 mmol) and oxazole 
(0.138 g, 2 mmol), product 22b was obtained in 80% yield 
(0.117 g) as a yellow solid: mp 113-115 °C.  1H NMR (400 
MHz, CDCl3):  9.28 (s, 1H), 8.67 (d, J = 3.9 Hz, 1H), 
8.29 (dt, J = 8.0, 1.0 Hz, 1H), 7.76 (d, J = 0.5 Hz, 1H), 
7.39 (dd, J = 8.0, 3.9 Hz, 1H), 7.27 (d, J = 0.5 Hz, 1H).  
13C NMR (100 MHz, CDCl3):  159.8, 151.2, 147.8, 139.4, 
133.7, 128.9, 123.9, 123.7.  LRMS calcd for M+ C8H6N2O 
146, found 146. 
2-(Pyridin-4-yl)oxazole (23b):[25] Following procedure B, 
from 4-bromopyridine hydrochloride (0.194 g, 1 mmol), 
oxazole (0.138 g, 2 mmol) and Cs2CO3 (1.304 g, 4 mmol), 
product 23b was obtained in 78% yield (0.114 g) as a 
yellow solid: mp 113-115 °C.  1H NMR (400 MHz, 
CDCl3):  8.74 (d, J = 6.0 Hz, 2H), 7.88 (d, J = 6.0 Hz, 
1H), 7.79 (s, 1H), 7.32 (s, 1H).  13C NMR (100 MHz, 
CDCl3):  159.7, 150.6, 139.8, 134.2, 129.2, 120.0.  LRMS 
calcd for M+ C8H6N2O 146, found 146. 
2,5-Di(quinolin-3-yl)oxazole (1c): Following procedure 
C, from 3-bromoquinoline (0.624 g, 3 mmol) and oxazole 
(0.069 g, 2 mmol), product 1c was obtained in 74% yield 
(0.239 g) as a yellow solid: mp 265-267 °C.  1H NMR (400 
MHz, CDCl3):  9.68 (d, J = 2.1 Hz, 1H), 9.30 (d, J = 2.1 
Hz, 1H), 8.90 (d, J = 2.0 Hz, 1H), 8.53 (d, J = 2.0 Hz, 1H), 
8.20 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 8.4 Hz, 1H), 7.99 (d, 
J = 7.9 Hz, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.82 (td, J = 7.5, 
1.4 Hz, 1H), 7.80-7.75 (m, 2H), 7.68-7.61 (m, 2H).  13C 
NMR (100 MHz, CDCl3):  160.0, 149.6, 148.7, 147.9, 
147.8, 146.6, 133.6, 131.0, 130.4, 130.2, 129.6, 129.5, 
128.5, 128.1, 127.7, 127.6, 127.3, 125.2, 121.1, 120.4.  
Anal. Calcd for C21H13N3O (323.36): C, 78.00; H, 4.05. 
Found: C, 78.25; H, 4.02.  HRMS calcd for M+Na 
C21H13N3NaO 346.0951, found 346.0949. 
4,4'-(Oxazole-2,5-diyl)dibenzonitrile (3c):[26] Following 
procedure C, from 4-bromobenzonitrile (0.546 g, 3 mmol) 
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and oxazole (0.069 g, 1 mmol), product 3c was obtained in 
17% yield (0.046 g) as a white solid: mp 265-267 °C.  1H 
NMR (400 MHz, CDCl3):  8.25 (d, J = 8.6 Hz, 2H), 7.86 
(d, J = 8.6 Hz, 2H), 7.83 (d, J = 8.6 Hz, 2H), 7.78 (d, J = 
8.6 Hz, 2H), 7.68 (s, 1H).  13C NMR (100 MHz, CDCl3):  
160.6, 150.7, 133.1, 132.9, 131.5, 130.7, 127.1, 126.8, 
124.8, 118.5, 118.3, 114.4, 112.4.  LRMS calcd for M+ 
C17H9N3O 271, found 271. 
2,5-Bis(4-(trifluoromethyl)phenyl)oxazole (8c):[7a] 
Following procedure C, from 4-
(trifluoromethyl)bromobenzene (0.675 g, 3 mmol) and 
oxazole (0.069 g, 1 mmol), product 8c was obtained in 
60% yield (0.214 g) as a white solid: mp 127-129 °C.  1H 
NMR (400 MHz, CDCl3):  8.24 (d, J = 8.5 Hz, 2H), 7.84 
(d, J = 8.5 Hz, 2H), 7.77 (d, J = 8.5 Hz, 2H), 7.72 (d, J = 
8.5 Hz, 2H), 7.60 (s, 1H).  13C NMR (100 MHz, CDCl3):  
160.5, 150.6, 132.3 (q, J = 32.7 Hz), 130.8 (m), 130.6 (q, J 
= 32.7 Hz), 130.2 (m), 126.7, 126.1 (q, J = 3.8 Hz), 125.9 
(q, J = 3.8 Hz), 125.5, 124.4, 123.8 (q, J = 272.0 Hz), 
123.7 (q, J = 272.0 Hz).  LRMS calcd for M+ C17H9F6NO 
357, found 357. 
2,5-Bis(4-chlorophenyl)oxazole (9c):[27] Following 
procedure C, from 4-bromochlorobenzene (0.573 g, 3 
mmol) and oxazole (0.069 g, 2 mmol), product 9c was 
obtained in 71% yield (0.206 g) as a white solid: mp 146-
148 °C.  1H NMR (400 MHz, CDCl3):  8.03 (d, J = 8.4 
Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 7.46 (d, J = 8.4 Hz, 2H), 
7.43 (s, 1H), 7.42 (d, J = 8.4 Hz, 2H).  13C NMR (100 
MHz, CDCl3):  160.4, 150.5, 136.6, 134.4, 129.3, 129.2, 
127.6, 126.3, 125.7, 125.4, 123.9.  LRMS calcd for M+ 
C15H9Cl2NO 289, found 289. 
2,5-Bis(4-fluorophenyl)oxazole (10c):[28] Following 
procedure C, from 4-bromofluorobenzene (0.525 g, 3 
mmol) and oxazole (0.069 g, 2 mmol), product 10c was 
obtained in 73% yield (0.188 g) as a white solid: mp 154-
156 °C.  1H NMR (400 MHz, CDCl3):  8.09 (dd, J = 8.2 , 
5.3 Hz, 2H), 7.69 (dd, J = 8.2, 5.3 Hz, 2H), 7.37 (s, 1H), 
7.22-7.12 (m, 4H).  13C NMR (100 MHz, CDCl3):  165.5, 
162.9 (d, J = 249.1 Hz), 161.8 (d, J = 250.2 Hz), 150.7, 
128.5 (d, J = 8.7 Hz), 126.2 (d, J = 8.2 Hz), 124.4, 123.9, 
123.2, 116.3 (d, J = 22.1 Hz), 116.2 (d, J = 22.1 Hz).  
LRMS calcd for M+ C15H9F2NO 257, found 257. 
2,5-Diphenyloxazole (11c):[27] Following procedure C, 
from bromobenzene (0.471 g, 3 mmol) and oxazole (0.069 
g, 2 mmol), product 11c was obtained in 69% yield (0.152 
g) as a white solid: mp 78-80 °C.  1H NMR (400 MHz, 
CDCl3):  8.12 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 8.4 Hz, 
2H), 7.51-7.42 (m, 6H), 7.34 (t, J = 7.8 Hz, 1H).  13C NMR 
(100 MHz, CDCl3):  161.3, 151.4, 130.5, 129.1, 129.0, 
128.6, 128.2, 127.6, 126.4, 124.4, 123.6.  LRMS calcd for 
M+ C15H11NO 221, found 221. 
2,5-Bis(4-methoxyphenyl)oxazole (13c):[27] Following 
procedure C, from 4-bromoanisole (0.561 g, 3 mmol) and 
oxazole (0.069 g, 2 mmol), product 13c was obtained in 
53% yield (0.149 g) as a white solid: mp 143-145 °C.  1H 
NMR (400 MHz, CDCl3):  8.03 (d, J = 8.4 Hz, 2H), 7.63 
(d, J = 8.4 Hz, 2H), 7.28 (s, 1H), 6.99 (d, J = 8.4 Hz, 2H), 
7.97 (d, J = 8.4 Hz, 2H), 3.87 (s, 3H), 3.85 (s, 3H).  13C 
NMR (100 MHz, CDCl3):  161.3, 160.8, 159.8, 150.9, 
127.9, 125.7, 121.9, 121.2, 120.6, 114.5, 114.3, 55.5 (2C).  
LRMS calcd for M+ C17H15NO3 281, found 281. 
2,5-Di(naphthalen-1-yl)oxazole (21c):[29] Following 
procedure C, from 1-bromonaphthalene (0.621 g, 3 mmol) 
and oxazole (0.069 g, 2 mmol), product 21c was obtained 
in 81% yield (0.260 g) as a yellow solid: mp 96-98 °C.  1H 
NMR (400 MHz, CDCl3):  9.42 (d, J = 8.6 Hz, 1H), 8.44 
(d, J = 8.2 Hz, 1H), 8.36 (d, J = 8.0, 1.1 Hz, 1H), 8.00 (d, J 
= 8.2 Hz, 1H), 7.96-7.87 (m, 4H), 7.72-7.53 (m, 7H).  13C 
NMR (100 MHz, CDCl3):  161.5, 150.3, 134.0, 134.0, 
131.3, 130.3, 130.2, 129.6, 128.8, 128.6, 127.9, 127.7, 
127.2, 126.8, 126.5, 126.4, 126.3, 126.2, 125.5, 125.4, 
125.1, 125.0, 123.9.  LRMS calcd for M+ C23H15NO 321, 
found 321. 
4-(2-(4-Methoxyphenyl)oxazol-5-yl)benzonitrile (25): 
Following procedure A, from 4-bromobenzonitrile (0.364 
g, 2 mmol) and 2-(4-methoxyphenyl)oxazole 13b (0.175 g, 
1 mmol), product 25 was obtained in 85% yield (0.235 g) 
as a yellow solid: mp 175-177 °C.  1H NMR (400 MHz, 
CDCl3):  8.04 (d, J = 8.6 Hz, 2H), 7.77 (d, J = 8.6 Hz, 
2H), 7.71 (d, J = 8.6 Hz, 2H), 7.55 (s, 1H), 7.00 (d, J = 8.6 
Hz, 2H), 3.88 (s, 3H).  13C NMR (100 MHz, CDCl3):  
162.6, 161.9, 148.8, 132.8, 132.1, 128.3, 126.2, 124.2, 
119.6, 118.6, 114.4, 111.2, 55.5.  Anal. Calcd for 
C17H12N2O2 (276.30): C, 73.90; H, 4.38. Found: C, 74.15; 
H, 4.28.  LRMS calcd for M+ C17H12N2O2 276, found 276. 
4-(5-(4-Methoxyphenyl)oxazol-2-yl)benzonitrile (26): 
Following procedure A, from 4-bromoanisole (0.374 g, 2 
mmol) and 4-(oxazol-2-yl)benzonitrile 3b (0.170 g, 1 
mmol) at 150 °C, product 26 was obtained in 86% yield 
(0.237 g) a yellow solid: mp 157-159 °C.  1H NMR (400 
MHz, CDCl3):  8.18 (d, J = 8.6 Hz, 2H), 7.76 (d, J = 8.6 
Hz, 2H), 7.66 (d, J = 8.6 Hz, 2H), 7.38 (s, 1H), 6.99 (d, J = 
8.6 Hz, 2H), 3.87 (s, 3H).  13C NMR (100 MHz, CDCl3):  
160.3, 158.6, 152.6, 132.6, 131.3, 126.4, 126.0, 122.7, 
120.2, 118.4, 114.6, 113.2, 55.4.  Anal. Calcd for 
C17H12N2O2 (276.30): C, 73.90; H, 4.38. Found: C, 73.85; 
H, 4.51.  LRMS calcd for M+ C17H12N2O2 276, found 276. 
5-(4-Fluorophenyl)-2-(4-methoxyphenyl)oxazole (27): 
Following procedure A, from 4-bromofluorobenzene 
(0.350 g, 2 mmol) and 2-(4-methoxyphenyl)oxazole 13b 
(0.175 g, 1 mmol), product 27 was obtained in 77% yield 
(0.207 g) as a white solid: mp 131-133 °C.  1H NMR (400 
MHz, CDCl3):  8.03 (d, J = 8.6 Hz, 2H), 7.67 (dd, J = 8.6, 
5.2 Hz, 2H), 7.34 (s, 1H), 7.13 (t, J = 8.6 Hz, 2H), 6.99 (d, 
J = 8.6 Hz, 2H), 3.87 (s, 3H).  13C NMR (100 MHz, 
CDCl3):  162.6 (d, J = 248.5 Hz), 161.4, 161.3, 149.9, 
127.9, 125.9 (d, J = 8.2 Hz), 124.5 (d, J = 3.3 Hz), 122.9 
(d, J = 1.3 Hz), 120.2, 116.0 (d, J = 22.1 Hz), 114.3, 55.4.  
Anal. Calcd for C16H12FNO2 (269.28): C, 71.37; H, 4.49. 
Found: C, 71.56; H, 4.20.  LRMS calcd for M+ C16H12NO2 
269, found 269. 
5-(4-(tert-Butyl)phenyl)-2-(4-methoxyphenyl)oxazole 
(28): Following procedure A, from 1-bromo-4-tert-
butylbenzene (0.426 g, 2 mmol) and 2-(4-
methoxyphenyl)oxazole 13b (0.175 g, 1 mmol), product 28 
was obtained in 81% yield (0.249 g) as a white solid: mp 
111-113 °C.  1H NMR (400 MHz, CDCl3):  8.04 (d, J = 
8.6 Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 7.46 (d, J = 8.4 Hz, 
2H), 7.36 (s, 1H), 7.00 (d, J = 8.6 Hz, 2H), 3.87 (s, 3H), 
1.36 (s, 9H).  13C NMR (100 MHz, CDCl3):  161.3, 161.0, 
151.5, 150.9, 127.9, 125.8, 125.4, 123.9, 122.8, 120.4, 
114.2, 55.4, 34.8, 31.2.  Anal. Calcd for C20H21NO2 
(307.39): C, 78.15; H, 6.89. Found: C, 77.89; H, 6.98.  
LRMS calcd for M+ C20H21NO2 307, found 307. 
4-(2-(4-Fluorophenyl)oxazol-5-yl)benzonitrile (29): 
Following procedure B, from 4-bromofluorobenzene 
(0.350 g, 2 mmol) and 4-(oxazol-5-yl)benzonitrile 3a 
(0.170 g, 1 mmol), product 29 was obtained in 79% yield 
(0.208 g) as a white solid: mp 209-211 °C.  1H NMR (400 
MHz, CDCl3):  8.11 (dd, J = 8.6, 5.3 Hz, 2H), 7.79 (d, J = 
8.5 Hz, 2H), 7.73 (d, J = 8.5 Hz, 2H), 7.57 (s, 1H), 7.19 (t, 
J = 8.6 Hz, 2H).  13C NMR (100 MHz, CDCl3):  164.4 (d, 
J = 252.2 Hz), 161.6, 149.4, 132.8, 131.8, 128.7 (d, J = 8.7 
Hz), 126.2, 124.3, 123.2 (d, J = 3.3 Hz), 118.5, 116.2 (d, J 
= 22.2 Hz), 111.6.  Anal. Calcd for C16H9FN2O (264.26): 
C, 72.72; H, 3.43. Found: C, 72.89; H, 3.62.  LRMS calcd 
for M+ C16H9FN2O 264, found 264. 
4-(2-(4-(tert-Butyl)phenyl)oxazol-5-yl)benzonitrile (30): 
Following procedure B, from 1-bromo-4-tert-butylbenzene 
(0.426 g, 2 mmol) and 4-(oxazol-5-yl)benzonitrile 3a 
(0.170 g, 1 mmol), product 30 was obtained in 77% yield 
(0.232 g) as a yellow solid: mp 157-159 °C.  1H NMR (400 
MHz, CDCl3):  8.03 (d, J = 8.4 Hz, 2H), 7.79 (d, J = 8.5 
Hz, 2H), 7.71 (d, J = 8.5 Hz, 2H), 7.57 (s, 1H), 7.52 (d, J = 
8.4 Hz, 2H), 1.37 (s, 9H).  13C NMR (100 MHz, CDCl3):  
162.6, 154.5, 149.1, 132.8, 132.0, 126.4, 126.3, 125.9, 
124.3, 124.1, 118.6, 111.3, 35.0, 31.2.  Anal. Calcd for 
C20H18N2O (302.38): C, 79.44; H, 6.00. Found: C, 79.65; 
H, 5.82.  LRMS calcd for M+ C20H18N2O 302, found 302. 
5-([1,1'-Biphenyl]-2-yl)-2-(4-methoxyphenyl)oxazole 
(31a): Following procedure A, from 2-bromobiphenyl 
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(0.466 g, 2 mmol) and 2-(4-methoxyphenyl)oxazole 13b 
(0.175 g, 1 mmol), product 31a was obtained in 83% yield 
(0.271 g) as a white solid: mp 126-128 °C.  1H NMR (400 
MHz, CDCl3):  7.86 (d, J = 8.6 Hz, 3H), 7.49-7.31 (m, 
8H), 6.94 (d, J = 8.6 Hz, 2H), 6.38 (s, 1H), 3.83 (s, 3H).  
13C NMR (100 MHz, CDCl3):  161.3, 160.7, 149.7, 141.6, 
139.8, 130.8, 128.9, 128.6, 128.0, 127.9, 127.7, 127.6, 
126.8, 126.6, 126.3, 120.2, 114.2, 55.4.  Anal. Calcd for 
C22H17NO2 (327.38): C, 80.71; H, 5.23. Found: C, 80.89; 
H, 5.05.  LRMS calcd for M+ C22H17NO2 327, found 327. 
5-([1,1'-Biphenyl]-2-yl)-2-(4-chlorophenyl)oxazole 
(32a): Following procedure A, from 2-bromobiphenyl 
(0.466 g, 2 mmol) and 2-(4-chlorophenyl)oxazole 9b 
(0.180 g, 1 mmol), product 32a was obtained in 80% yield 
(0.265 g) as a yellow solid: mp 153-155 °C.  1H NMR (400 
MHz, CDCl3):  7.84 (d, J = 8.6 Hz, 1H), 7.82 (d, J = 8.6 
Hz, 2H), 7.45 (td, J = 7.6, 1.5 Hz, 1H), 7.42-7.29 (m, 9H), 
6.42 (s, 1H).  13C NMR (100 MHz, CDCl3):  159.6, 150.6, 
141.4, 140.0, 136.2, 130.8, 129.0, 128.9, 128.5, 128.4, 
127.8, 127.6, 127.4, 126.7, 126.5, 126.4, 125.8.  Anal. 
Calcd for C21H14ClNO (331.80): C, 76.02; H, 4.25. Found: 
C, 76.31; H, 4.02.  LRMS calcd for M+ C21H14ClNO 331, 
found 331. 
5-([1,1'-Biphenyl]-2-yl)-2-(4-
(trifluoromethyl)phenyl)oxazole (33a): Following 
procedure A, from 2-bromobiphenyl (0.466 g, 2 mmol) and 
2-(4-(trifluoromethyl)phenyl)oxazole 8b (0.213 g, 1 
mmol), product 33a was obtained in 88% yield (0.321 g) 
as a yellow solid: mp 85-87 °C.  1H NMR (400 MHz, 
CDCl3):  7.98 (d, J = 8.3 Hz, 2H), 7.86 (d, J = 8.6 Hz, 
1H), 7.68 (d, J = 8.3 Hz, 2H), 7.49 (td, J = 7.6, 1.5 Hz, 
1H), 7.45-7.31 (m, 7H), 6.52 (s, 1H).  13C NMR (100 
MHz, CDCl3):  159.1, 151.2, 141.4, 140.2, 131.6 (q, J = 
32.5 Hz), 130.9, 130.5, 128.9, 128.6, 128.5, 127.8, 127.7, 
126.9, 126.7, 126.3, 126.2, 125.7 (q, J = 3.7 Hz), 123.8 (q, 
J = 272.3 Hz).  Anal. Calcd for C22H14F3NO (365.36): C, 
72.32; H, 3.86. Found: C, 72.12; H, 4.07.  LRMS calcd for 
M+ C22H14NO 365, found 365. 
5-([1,1'-Biphenyl]-2-yl)-4-bromo-2-(4-
methoxyphenyl)oxazole (31b): The reaction of 5-([1,1'-
biphenyl]-2-yl)-2-(4-methoxyphenyl)oxazole 31a (0.245 g, 
0.75 mmol), N-bromosuccinimide (0.267 g, 1.5 mmol) at 
25 °C during 16 h in DMF (4 mL) under argon affords the 
coupling product 31b after evaporation of the solvent and 
purification on silica gel in 84% yield (0.256 g) as a yellow 
oil.  Eluent heptane:ethyl acetate: 9:1.  1H NMR (400 
MHz, CDCl3):  7.80 (d, J = 8.6 Hz, 1H), 7.56 (d, J = 8.6 
Hz, 2H), 7.53-7.44 (m, 3H), 7.36-7.25 (m, 5H), 6.85 (d, J 
= 8.6 Hz, 2H), 3.82 (s, 3H).  13C NMR (100 MHz, CDCl3): 
 161.7, 160.6, 146.4, 141.8, 141.2, 130.8, 130.0, 129.8, 
128.7, 128.2, 127.9, 127.3, 127.2, 125.3, 119.1, 114.6, 
114.1, 55.4.  LRMS calcd for M+ C22H12BrNO2 405, found 
405. 
5-([1,1'-Biphenyl]-2-yl)-4-bromo-2-(4-
chlorophenyl)oxazole (32b): The reaction of 5-([1,1'-
biphenyl]-2-yl)-2-(4-chlorophenyl)oxazole 32a (0.248 g, 
0.75 mmol), N-bromosuccinimide (0.267 g, 1.5 mmol) at 
25 °C during 16 h in DMF (4 mL) under argon affords the 
coupling product 32b after evaporation of the solvent and 
purification on silica gel in 86% yield (0.264 g) as a yellow 
oil.  Eluent heptane:ethyl acetate: 9:1.  1H NMR (400 
MHz, CDCl3):  7.81 (d, J = 8.6 Hz, 1H), 7.57-7.46 (m, 
5H), 7.35-7.24 (m, 7H).  13C NMR (100 MHz, CDCl3):  
159.5, 147.3, 141.9, 141.1, 136.9, 130.8, 130.1, 130.0, 
129.0, 128.7, 128.2, 127.4, 127.3, 127.2, 124.9, 124.8, 
114.8.  LRMS calcd for M+ C21H13ClBrNO 411, found 
411. 
5-([1,1'-Biphenyl]-2-yl)-4-bromo-2-(4-
(trifluoromethyl)phenyl)oxazole (33b): The reaction of 
5-([1,1'-biphenyl]-2-yl)-2-(4-
(trifluoromethyl)phenyl)oxazole 33a (0.273 g, 0.75 mmol), 
N-bromosuccinimide (0.267 g, 1.5 mmol) at 25 °C during 
16 h in DMF (4 mL) under argon affords the coupling 
product 33b after evaporation of the solvent and 
purification on silica gel in 83% yield (0.276 g) as a yellow 
oil.  Eluent heptane:ethyl acetate: 9:1.  1H NMR (400 
MHz, CDCl3):  7.84 (d, J = 8.6 Hz, 1H), 7.70 (d, J = 8.2 
Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H), 7.58-7.48 (m, 3H), 7.37-
7.26 (m, 5H).  13C NMR (100 MHz, CDCl3):  159.0, 
148.0, 142.0, 141.1, 132.2 (q, J = 32.5 Hz), 130.8, 130.2, 
130.0, 129.4, 128.7, 128.3, 127.4, 127.3, 126.3, 125.7 (q, J 
= 3.7 Hz), 124.8, 124.0 (q, J = 272.3 Hz), 115.1.  LRMS 
calcd for M+ C22H13BrF3NO 444, found 444. 
2-(4-Methoxyphenyl)phenanthro[9,10-d]oxazole 
(31c):[30] The reaction of 5-([1,1'-biphenyl]-2-yl)-4-bromo-
2-(4-methoxyphenyl)oxazole 31b (0.203 g, 0.5 mmol), 
KOPiv (0.140 g, 1 mmol) in the presence of 
PdCl(C3H5)(dppb) (15.2 mg, 0.025 mmol) at 150 °C during 
24 h in DMA (4 mL) under argon affords the coupling 
product 31c after evaporation of the solvent and 
purification on silica gel in 94% yield (0.152 g) as a white 
solid: mp 230-232 °C.  Eluent heptane:ethyl acetate: 9:1.  
1H NMR (400 MHz, CDCl3):  8.74 (t, J = 8.6 Hz, 2H), 
8.62 (d, J = 7.9 Hz, 1H), 8.32 (d, J = 7.0 Hz, 3H), 7.77-
7.65 (m, 4H), 7.07 (d, J = 8.7 Hz, 2H), 3.92 (s, 3H).  13C 
NMR (100 MHz, CDCl3):  162.4, 161.9, 144.6, 135.6, 
129.1, 128.9, 128.8, 127.3, 127.2, 126.2, 126.1, 126.0, 
123.7, 123.4, 122.9, 121.2, 120.7, 120.3, 114.4, 55.5.  
LRMS calcd for M+ C22H15NO2 325, found 325. 
2-(4-Chlorophenyl)phenanthro[9,10-d]oxazole (32c):[30] 
The reaction of 5-([1,1'-biphenyl]-2-yl)-4-bromo-2-(4-
chlorophenyl)oxazole 32b (0.205 g, 0.5 mmol), KOPiv 
(0.140 g, 1 mmol) in the presence of PdCl(C3H5)(dppb) 
(15.2 mg, 0.025 mmol) at 150 °C during 24 h in DMA (4 
mL) under argon affords the coupling product 32c after 
evaporation of the solvent and purification on silica gel in 
90% yield (0.148 g) as a white solid: mp 261-263 °C.  
Eluent heptane:ethyl acetate: 9:1.  1H NMR (400 MHz, 
CDCl3):  8.78 (t, J = 8.6 Hz, 2H), 8.59 (d, J = 7.9 Hz, 
1H), 8.40-8.26 (m, 3H), 7.80-7.65 (m, 4H), 7.58 (d, J = 8.6 
Hz, 2H).  13C NMR (100 MHz, CDCl3):  161.2, 145.0, 
137.0, 135.5, 129.4, 129.3, 128.9, 128.4, 127.6, 127.5, 
126.6, 126.3, 126.2, 126.1, 123.8, 123.5, 122.7, 121.0, 
120.8.  LRMS calcd for M+ C21H12ClNO 329, found 329. 
2-(4-(Trifluoromethyl)phenyl)phenanthro[9,10-
d]oxazole (33c): The reaction of 5-([1,1'-biphenyl]-2-yl)-
4-bromo-2-(4-(trifluoromethyl)phenyl)oxazole 33b (0.222 
g, 0.5 mmol), KOPiv (0.140 g, 1 mmol) in the presence of 
PdCl(C3H5)(dppb) (15.2 mg, 0.025 mmol) at 150 °C during 
24 h in DMA (4 mL) under argon affords the coupling 
product 33c after evaporation of the solvent and 
purification on silica gel in 96% yield (0.174 g) as a white 
solid: mp 223-225 °C.  Eluent heptane:ethyl acetate: 9:1.  
1H NMR (400 MHz, CDCl3):  8.74 (t, J = 8.6 Hz, 2H), 
8.62 (d, J = 7.9 Hz, 1H), 8.47 (d, J = 7.4 Hz, 2H), 8.34 (d, 
J = 6.7 Hz, 1H), 7.85-7.65 (m, 6H).  13C NMR (100 MHz, 
CDCl3):  160.6, 145.3, 135.6, 132.4 (q, J = 32.7 Hz), 
130.7, 129.6, 129.0, 127.9, 127.6, 127.4, 126.8, 126.4, 
126.0, 125.9 (q, J = 3.8 Hz), 123.8, 123.7 (q, J = 272.6 
Hz), 123.5, 122.9, 121.0, 120.9.  Anal. Calcd for 
C22H12F3NO (363.34): C, 72.73; H, 3.33. Found: C, 72.89; 
H, 3.20.  LRMS calcd for M+ C22H12F3NO 363, found 363. 
4'-Methoxy-2-(oxazol-2-yl)-[1,1'-biphenyl]-3-
carbonitrile (34): The reaction of 4-bromoanisole (0.374 
g, 2 mmol), 2-(oxazol-2-yl)benzonitrile 18b (0.170 g, 1 
mmol), KOPiv (0.280 g, 2 mmol) in the presence of [Ru(p-
cymene)Cl2]2 (30.6 mg, 0.05 mmol) at 150 °C during 16 h 
in NMP (4 mL) under argon affords the coupling product 
34 after evaporation of the solvent and purification on 
silica gel in 43% yield (0.119 g) as a white solid: mp 101-
103 °C.  Eluent heptane:ethyl acetate: 7:3.  1H NMR (400 
MHz, CD2Cl2):  7.78 (d, J = 7.4 Hz, 1H), 7.71 (d, J = 7.8 
Hz, 1H), 7.67-7.61 (m, 2H), 7.26 (s, 1H), 7.06 (d, J = 8.6 
Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H).  13C NMR 
(100 MHz, CD2Cl2):  159.5, 158.1, 143.7, 139.8, 134.6, 
132.0, 131.2, 130.6, 129.7, 129.5, 128.2, 117.2, 114.2, 
113.9, 55.2.  Anal. Calcd for C17H12N2O2 (276.30): C, 
73.90; H, 4.38. Found: C, 73.68; H, 4.21.  LRMS calcd for 
M+ C17H12N2O2 276, found 276. 
2-(Oxazol-2-yl)-[1,1'-biphenyl]-3,4'-dicarbonitrile (35): 
The reaction of 4-bromobenzonitrile (0.364 g, 2 mmol), 2-
(oxazol-2-yl)benzonitrile 18b (0.170 g, 1 mmol), KOPiv 
(0.280 g, 2 mmol) in the presence of [Ru(p-cymene)Cl2]2 
(30.6 mg, 0.05 mmol) at 150 °C during 16 h in NMP (4 
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mL) under argon affords the coupling product 35 after 
evaporation of the solvent and purification on silica gel in 
62% yield (0.168 g) as a white solid: mp 183-185 °C.  
Eluent heptane:ethyl acetate: 6:4.  1H NMR (400 MHz, 
CD2Cl2):  7.89 (dd, J = 6.1, 2.9 Hz, 1H), 7.75-7.68 (m, 
2H), 7.67-7.62 (m, 3H), 7.28-7.23 (m, 3H).  13C NMR (100 
MHz, CD2Cl2):  157.2, 143.7, 142.0, 140.1, 134.3, 133.6, 
132.2, 130.8, 129.7, 129.2, 128.4, 118.4, 116.9, 114.2, 
111.9.  Anal. Calcd for C17H9N3O (271.28): C, 75.27; H, 
3.34. Found: C, 75.60; H, 3.54.  LRMS calcd for M+ 
C17H9N3O 271, found 271. 
4-(1-(Oxazol-2-yl)naphthalen-2-yl)benzonitrile (36): 
The reaction of 4-bromobenzonitrile (0.364 g, 2 mmol), 2-
(naphthalen-1-yl)oxazole 21b (0.195 g, 1 mmol), KOPiv 
(0.280 g, 2 mmol) in the presence of [Ru(p-cymene)Cl2]2 
(30.6 mg, 0.05 mmol) at 150 °C during 16 h in NMP (4 
mL) under argon affords the coupling product 36 after 
evaporation of the solvent and purification on silica gel in 
83% yield (0.246 g) as a yellow solid: mp 161-163 °C.  
Eluent heptane:ethyl acetate: 7:3.  1H NMR (400 MHz, 
CD2Cl2):  8.08 (d, J = 8.8 Hz, 1H), 7.99-7.90 (m, 2H), 
7.66-7.52 (m, 6H), 7.34 (d, J = 8.5 Hz, 2H), 7.29 (s, 1H).  
13C NMR (100 MHz, CD2Cl2):  159.7, 145.9, 139.3, 
139.1, 132.9, 132.4, 132.0, 131.1, 129.5, 128.2, 128.0, 
127.9, 127.0, 126.8, 125.7, 124.3, 118.8, 111.0.  Anal. 
Calcd for C20H12N2O (296.33): C, 81.07; H, 4.08. Found: 
C, 81.23; H, 4.32.  LRMS calcd for M+ C20H12N2O 296, 
found 296. 
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